Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model
Mustafa K Shehata, Assem A Ismail, Maher A. Kamel
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4193-4227
Open Access | Times Cited: 15

Showing 15 citing articles:

Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights
Kumari Komal, Rashmi Ghosh, Debayan Sil, et al.
Inflammopharmacology (2025)
Closed Access | Times Cited: 1
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Young‐Ju Jang, Seong-Jun Kang, Hyun Su Park, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease
Bhagavathi Sundaram Sivamaruthi, Neha R. Raghani, Mehul R. Chorawala, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2587-2587
Open Access | Times Cited: 36
Astaxanthin-loaded brain-permeable liposomes for Parkinson’s disease treatment via antioxidant and anti-inflammatory responses
Thuy-vi Nguyen, Shristi Khanal, Eun-Hee Lee, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
Fanjing Kong, Tianyu Wu, Jiyan Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Innovative Nano Delivery Systems for Astaxanthin: Enhancing Stability, Bioavailability, and Targeted Therapeutic Applications
Lei Jia, Wei Wang, Hongyu Zhao, et al.
Journal of Agricultural and Food Chemistry (2025) Vol. 73, Iss. 6, pp. 3286-3304
Closed Access
Spectroscopic Characterization Using 1H and 13C Nuclear Magnetic Resonance and Computational Analysis of the Complex of Donepezil with 2,6-Methyl-β-Cyclodextrin and Hydroxy Propyl Methyl Cellulose
Nikoletta Zoupanou, Paraskevi Papakyriakopoulou, Nikitas Georgiou, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1169-1169
Open Access
A marine-derived antioxidant astaxanthin as a potential neuroprotective and neurotherapeutic agent: A review of its efficacy on neurodegenerative conditions
Emre Adıgüzel, Taha Gökmen Ülger
European Journal of Pharmacology (2024) Vol. 977, pp. 176706-176706
Closed Access | Times Cited: 4
Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro
David Lee, Andrew M. Shen, Olga B. Garbuzenko, et al.
The AAPS Journal (2024) Vol. 26, Iss. 5
Open Access | Times Cited: 4
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Devank Shekho, Ritika Mishra, Raj Kamal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 2
Evolution of lipid nanoparticles as charioteers of Alzheimer's disease therapeutics
Brati Chakraborty, Gayatri Patel, Bandana Padhan, et al.
Applied Materials Today (2024) Vol. 41, pp. 102442-102442
Closed Access | Times Cited: 2
Research progress of neurovascular units involved in ischemic stroke
Yu Yang, Tong Hao, Zhuo‐Fan Ye, et al.
Ibrain (2024)
Open Access | Times Cited: 1
Neuroprotective effects of traditional Chinese medicine Naofucong on diabetic cognitive impairment: Mechanisms involving insulin-degrading enzyme-mediated degradation of Amyloid-β and inhibition of ERK/JNK/p38 MAPK signaling pathway
Yue Tian, Guangchan Jing, Ruiying Yin, et al.
Brain Research (2024), pp. 149365-149365
Open Access | Times Cited: 1
Co-administration of Ceratonia siliqua extract nanoparticles promotes the oral bioavailability and neurotherapeutic efficacy of donepezil in a dementia model
Sylvia E. Shaker, Dalia B. Fayed, Heba Shawky, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 77, Iss. 1, pp. 153-169
Closed Access
Nose to Brain: Exploring the Progress of Intranasal Delivery of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
Yang Zheng, Limei Cui, Haoran Lu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 12343-12368
Open Access
Biological activities of astaxanthin in the treatment of neurodegenerative diseases
Alireza Lotfi, Zahra Abroodi, Mozafar Khazaei
Neurodegenerative Disease Management (2024), pp. 1-16
Closed Access
Page 1

Scroll to top